Application of Lentiviral Vectors for Development of Production Cell Lines and Safety Testing of Lentiviral-Derived Cells or Products

References

1. 1.↵
   1. Vigna E.,
   2. Naldini L.

   Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2000, 2 (5), 308–316.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
2. 2.↵
   1. Naldini L.,
   2. Blomer U.,
   3. Gallay P.,
   4. Ory D.,
   5. Mulligan R.,
   6. Gage F. H.,
   7. Verma I. M.,
   8. Trono D.

   In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272 (5259), 263–267.

   OpenUrlAbstractGoogle Scholar
3. 3.↵
   1. Marsh M.,
   2. Helenius A.

   Virus entry into animal cells. Adv. Virus Res. 1989, 36, 107–151.

   OpenUrlPubMedWeb of ScienceGoogle Scholar
4. 4.↵
   1. Bukrinsky M. I.,
   2. Haffar O. K.

   HIV-1 nuclear import: in search of a leader. Front. Biosci. 1999, 4, 772–781.

   OpenUrlGoogle Scholar
5. 5.↵
   1. D'Costa J.,
   2. Mansfield S. G.,
   3. Humeau L. M.

   Lentiviral vectors in clinical trials: Current status. Curr. Opin. Mol. Ther. 2009, 11 (5), 554–564.

   OpenUrlPubMedGoogle Scholar
6. 6.↵
   1. Sastry L.,
   2. Cornetta K.

   Detection of replication competent retrovirus and lentivirus. Methods Mol. Biol. 2009, 506, 243–263.

   OpenUrlPubMedGoogle Scholar
7. 7.↵
   1. Escarpe P.,
   2. Zayek N.,
   3. Chin P.,
   4. Borellini F.,
   5. Zufferey R.,
   6. Veres G.,
   7. Kiermer V.

   Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol. Ther. 2003, 8 (2), 332–341.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
8. 8.↵
   1. Lombardo A.,
   2. Genovese P.,
   3. Beausejour C. M.,
   4. Colleoni S.,
   5. Lee Y.-L.,
   6. Kim K. A.,
   7. Ando D.,
   8. Urnov F. D.,
   9. Galli C.,
   10. Gregory P. D.,
   11. Holmes M. C.,
   12. Naldini L.

   Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 2007, 25 (11), 1298–1306.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
9. 9.↵
   1. Hartman T. E.,
   2. Sar N.,
   3. Genereux K.,
   4. Baritt D. S.,
   5. He Y.,
   6. Burky J. E.,
   7. Wesson M. C.,
   8. Tso J. Y.,
   9. Tsurushita N.,
   10. Zhou W.,
   11. Sauer P. W.

   Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies. Biotechnol. Bioeng. 2007, 96 (2), 294–306.

   OpenUrlPubMedGoogle Scholar
10. 10.↵
    1. Gerolami R.,
    2. Uch R.,
    3. Jordier F.,
    4. Chapel S.,
    5. Bagnis C.,
    6. Brechot C.,
    7. Mannoni P.

    Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors. Cancer Gene Ther. 2000, 7 (9), 1286–1292.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
11. 11.↵
    1. Dingermann T.

    Recombinant therapeutic proteins: production platforms and challenges. Biotechnol. J. 2008, 3 (1), 90–97.

    OpenUrlCrossRefPubMedGoogle Scholar
12. 12.↵
    1. Segura M. M.,
    2. Garnier A.,
    3. Durocher Y.,
    4. Coelho H.,
    5. Kamen A.

    Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol. Bioeng. 2007, 98 (4), 789–799.

    OpenUrlPubMedGoogle Scholar